Metabolic Storage Disease Gene Mutation Panel, NGS
Metabolic storage diseases comprise a wide variety of rare and potentially fatal genetic disorders resulting in abnormal accumulation of biomolecules. Most metabolic storage diseases are due to mutations in genes that encode for enzymes responsible for the breakdown of these biomolecules. For example, in glycogen storage diseases (GSDs), one or more enzymes of glycogen breakdown are genetically altered leading to failed glycogenolysis and increased accumulation of glycogen in tissues. There are various types of glycogen storage diseases depending on the mutated enzyme involved. The most common types of glycogen storage diseases are GSD I, GSD II, GSD III, and GSD IV.
GSD I called von Gierke disease and is of two types: Ia and Ib. Type Ia GSD is due to mutations in the gene G6PC, located at 17q21, which is responsible for the formation of glucose-6-phosphatase (G6P) enzyme. Type Ib GSD is a result of mutations in the gene SLC37A4 (11q23.3), which leads to a defect in the transporter of G6P. GSD II, also called Pompe disease occurs due to mutations of the GAA gene (17q25.5-q25.3), leading to deficiency of enzyme acid alpha-glucosidase. GSD I leads to the accumulation of glycogen mainly in the liver, intestine, and kidney, while patients with GSD II present with cardiomyopathy and muscular hypertonia as glycogen accumulates in muscles, heart, liver, and nervous system.
Similarly, lipid storage diseases such as Gaucher and Niemann-Pick are due to genetic mutations resulting in a deficiency of enzymes necessary for the breakdown of lipids. Gaucher disease is due to mutation in the GBA gene resulting in deficiency of the enzyme glucocerebrosidase resulting in the accumulation of glucocerebroside. The general manifestations of Gaucher disease include an abnormally enlarged liver and/or spleen, anemia, thrombocytopenia, and skeletal abnormalities, however, the depending on the specific mutation the clinical spectrum varies from severe to subclinical. In Niemann-Pick disease, cells fail to metabolize sphingomyelin, leading to toxic accumulation. There are four types: A, B, C1, and C2. Mutations in the gene SMPD1 leads to types A and B while mutations in the NPC1 and NPC2 genes lead to type C1 and C2 Niemann-Pick disease respectively.
While testing of individual or a small group of genes based on clinical features is typically performed, in cases with atypical findings it can be time-consuming and delay the diagnosis of the specific genetic defect. Incorporation of the common genes involved in metabolic storage disorders in a panel offers the potential for earlier diagnosis.
A panel of 51 genes was recommended in 2019 that includes the following genes: AGA, ARSA, ARSB, ASAH1, , CHIT1, CLN3, CLN5, CLN6, CLN8, CTNS, CTSA, CTSC, CTSD, , CTSK, FUCA1, GAA, GALC, GALNS, GBA, GLA, GLB1, GM2A, GNPTAB, GNPTG, GNS, GUSB, HEXA, HEXB, HGSNAT, HYAL1, IDS, IDUA, , LAMP2, LIPA, MAN2B1, MANBA, MFSD8, NAGA, NAGLU, NEU1, NPC1, NPC2, PPT1, PSAP, SGSH, SLC17A5, SMPD1, SUMF1, STS, TPP1.
Depending on the laboratory additional genes may be included: ATP13A2, CTSF, DNAJC5, GFAP, GRN, KCTD7, MCOLN1, PANK2, AGL, ALDOA, ENO3, EPM2A, FBP1, G6PC, GBE1, GYG1, GYS1, GYS2, LDHA, NHLRC1, PFKM, PGAM2, PGK1, PGM1, PHKA1, PHKA2, PHKB, PHKG2, PRKAG2, PYGL, PYGM, RBCK1, SLC2A2, SLC37A4
- Diagnosis of glycogen storage disease
- Diagnosis of lipid storage diseases.
- Screening fetus for inborn errors of metabolism
- Postnatal diagnosis of metabolic storage diseases
- Selection of therapy and disease management.
Negative for mutations. (No mutations on the targeted genes were detected)
Whole blood (EDTA), buccal swab, saliva.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unstable
- World J Gastroenterol. 2007 May 14;13(18):2541-53. [PMID: 17552001]
- StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. [PMID: 30480935]
- StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. [PMID: 29262159]
- Orphanet J Rare Dis. 2011 May 20;6:27. [PMID: 21599942]
- GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. [PMID: 20301788]
- GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. [PMID: 20301489]
- GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. [PMID: 20301446]
- StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. [PMID: 32310589]
- Mol Genet Genomic Med 2019;7:e527 (PMID: 30548430]